Literature DB >> 7926603

Neuromodulation in molluscan smooth muscle: the action of 5-HT, FMRFamide and purine compounds.

I D Nelson1, H Huddart.   

Abstract

1. The RR, OR, RS and RP muscles of Buccinum did not respond directly to 5-HT, but this monoamine converted their normally tonic ACh responses to fast twitch contractions with lowered tonic force. This action was not accompanied by significant membrane potential changes. 2. Pre-treatment with dibutyryl cAMP potentiated ACh responses and enhanced 5-HT modification of the responses. 3. All muscles responded strongly to FMRFamide with twitch contractions but this was not accompanied by significant membrane potential changes. 4. FMRFamide enhanced ACh contracture force and converted the responses into fast twitch activity. FMRFamide responses were dramatically inhibited by 5-HT with loss of all tonic force and fast twitch activity. 5. While dibutyryl cAMP did not affect FMRFamide responses, the IP3 inhibitor lithium, at very high concentrations, caused a significant diminution of FMRFamide responses. 6. All four muscles were unresponsive to adenosine and ATP but all except the RP responded in a dose-dependent manner to GTP and GTP-gamma-S over the 10(-7) - 10(-4) mol l-1 range. The responses showed moderate fast twitch activity which was unaccompanied by action potential discharges. Guanosine was without effect, except at very high concentrations where it inhibited FMRFamide responses. 7. ACh and GTP acted additively to increase muscle force and to enhance ACh-induced depolarization. Similarly both GTP and GTP-gamma-S acted additively, considerably enhancing FMRFamide responses. 8. It is proposed that 5-HT, FMRFamide and GTP may, via their separate receptors or by possible interaction with ion channels, activate secondary messenger systems to modify the calcium released by ACh-induced depolarization to modulate excitation-contraction coupling and force generation in these muscles.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926603     DOI: 10.1016/0306-3623(94)90212-7

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  4 in total

1.  RFamide neuropeptide actions on molluscan proboscis smooth muscle: interactions with primary neurotransmitters.

Authors:  A Moulis; H Huddart
Journal:  J Comp Physiol B       Date:  2004-03-24       Impact factor: 2.200

2.  Comparative potency of some extended peptide chain members of the RFamide neuropeptide family, assessed on the hearts of Busycon canaliculatum and Buccinum undatum.

Authors:  A Moulis; H Huddart; R B Hill
Journal:  J Comp Physiol B       Date:  2003-08-21       Impact factor: 2.200

3.  Immunoaffinity-based mass spectrometric characterization of the FMRFamide-related peptide family in the pericardial organ of Cancer borealis.

Authors:  Mingming Ma; Robert M Sturm; Kimberly K Kutz-Naber; Qiang Fu; Lingjun Li
Journal:  Biochem Biophys Res Commun       Date:  2009-10-01       Impact factor: 3.575

4.  Changes in the neuropeptide content of Biomphalaria ganglia nervous system following Schistosoma infection.

Authors:  Tianfang Wang; Min Zhao; Di Liang; Utpal Bose; Satwant Kaur; Donald P McManus; Scott F Cummins
Journal:  Parasit Vectors       Date:  2017-06-02       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.